MassCPR Symposium 2025

Sponsored by Harvard Medical School, the Maxwell Finland Fund, and the Warren Alpert Foundation.

This year’s symposium will explore how the partnership between pharma and academia fuels breakthroughs that strengthen outbreak preparedness. Join colleagues from across the consortium, industry, public health, and academia for a lively exchange of ideas and insights. The event is sponsored by Harvard Medical School, the Maxwell Finland Fund, and the Warren Alpert Foundation.

Featured Speakers

  • Opening Remarks, 2025 Symposium Chair

    Bruce D. Walker
    The HMS Phillip T. and Susan M. Ragon Professor of Medicine, Massachusetts General Hospital
    Director, Ragon Institute

  • Moderator

    Gaurav Gaiha
    HMS Associate Professor of Medicine, Massachusetts General Hospital
    Principal Investigator, Ragon Institute

  • Keynote I

    Pirada Suphaphiphat Allen
    Pfizer
    From Moonshot to Flu-shot

  • Session I

    Lillian Juttukonda
    Boston Medical Center
    Unique cell states induced by common respiratory viruses in young children

    Yajuan Wang
    Boston Children’s Hospital
    Structural Basis of Coronavirus Genomic RNA Packaging

    Ninaad Lasrado
    Beth Israel Deaconess Medical Center
    Development of a Clade 2.3.4.4b H5N1 Avian Influenza Vaccine for Mucosal Protection

  • Keynote II

    Régis Gervier
    Sanofi
    Innovating for better outbreak interception

  • Session II

    Louise L. Hansen and Karan Malhotra
    Wyss Institute at Harvard
    Ultrasensitive Multi-Analyte Detection Assays for Predicting Disease Trajectories

    Adam Sychla
    Harvard Medical School
    High-Dimensional Profiling and Prediction of Zoonotic Spillover Risk in Hundreds of Picornaviridae

    Jarod Herrera
    Boston University Chobanian & Avedisian School of Medicine
    Developing Tools to Study the Pathogenic Potential of Newly Emerging Henipaviruses

  • Closing Remarks

    Nadine Fornelos Martins
    Executive Director of Research Initiatives, MassCPR